Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental autoimmune autonomic neuropathy.

Steven Vernino1, Phillip A Low, Vanda A Lennon

  • 1Department of Neurology, Mayo Graduate and Medical Schools, Mayo Clinic, Rochester, Minnesota 55905, USA.

Journal of Neurophysiology
|May 30, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precise disease heterogeneity and progression quantification in MSA and Parkinson's disease using machine learning.

Scientific reports·2026
Same author

Test-retest reliability of clinical supine-to-stand tests in patients with postural orthostatic tachycardia syndrome: A cautionary tale.

Heart rhythm·2026
Same author

Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia.

Annals of clinical and translational neurology·2025
Same author

A wolf in synuclein clothing: Creutzfeldt-Jakob disease disguised as MSA.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2025
Same author

Clinical Reasoning: A 66-Year-Old Man With Chronic Orthostatic Hypotension.

Neurology·2025
Same author

Letter to the editor regarding "Chronic autonomic symptom burden in long-COVID: a follow-up cohort study."

Clinical autonomic research : official journal of the Clinical Autonomic Research Society·2025

Autoimmune autonomic neuropathy (AAN) involves antibodies targeting neuronal nicotinic acetylcholine receptors (nAChRs). This study developed an animal model (experimental AAN) showing similar autonomic dysfunction and supporting nAChR antibodies as the cause.

Area of Science:

  • Neuroimmunology
  • Autonomic Neuroscience
  • Autoimmunity

Background:

  • Subacute autonomic failure, known as autoimmune autonomic neuropathy (AAN), is associated with high titers of antibodies against neuronal ganglionic nicotinic acetylcholine receptors (nAChRs).
  • The precise mechanisms and pathological features of AAN require further elucidation.
  • Understanding the role of nAChR antibodies in autonomic dysfunction is crucial for developing targeted therapies.

Purpose of the Study:

  • To establish and characterize an animal model of autoimmune autonomic neuropathy (AAN) using neuronal nAChR autoimmunity.
  • To investigate the correlation between ganglionic nAChR antibody levels and the severity of autonomic failure.
  • To define the physiological and histopathological characteristics of this experimental model.

Main Methods:

Related Experiment Videos

  • Rabbits were immunized with a neuronal nAChR alpha3 subunit fusion protein to induce experimental AAN (EAAN).
  • Quantitative measures of autonomic function were employed to assess physiological deficits.
  • Immunohistochemical staining of the superior cervical ganglia and myenteric plexus was performed to examine neuronal structure and nAChR localization.

Main Results:

  • The rabbit model successfully recapitulated cardinal autonomic features of human AAN, ranging from cardiovagal impairment to severe panautonomic failure.
  • Autonomic dysfunction severity, including fixed mydriasis, gastroparesis, and hypotension, correlated with serum antibody levels.
  • Histopathology revealed intact neurons with cytoplasmic nAChRs but a lack of surface nAChRs on presynaptic nerve terminals and postsynaptic neurons.

Conclusions:

  • The developed animal model provides a robust platform for studying neuronal nAChR autoimmunity and autonomic failure.
  • Findings support the hypothesis that AAN in humans results from ganglionic nAChR antibodies disrupting ganglionic cholinergic synaptic transmission.
  • This research clarifies the pathophysiology of AAN, highlighting the critical role of nAChR antibodies in autonomic nervous system dysfunction.